Antidepressants, benzodiazepines and azapirones for panic disorder in adults: A network meta-analysis
Guaiana G., Barbui C., Caldwell DM., Davies SJC., Furukawa TA., Imai H., Koesters M., Tajika A., Bighelli I., Pompoli A., Cipriani A.
© 2017 The Cochrane Collaboration. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare individual active drugs (antidepressants, benzodiazepines and azapirones) and placebo in terms of efficacy and acceptability in the acute treatment of panic disorder, with or without agoraphobia. To rank treatments for panic disorder (antidepressants, benzodiazepines, azapirones and placebo) according to their effectiveness and acceptability.